SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-186674
Filing Date
2024-07-29
Accepted
2024-07-29 06:46:30
Documents
15
Period of Report
2024-07-29
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d869952d8k.htm   iXBRL 8-K 23690
2 EX-99.1 d869952dex991.htm EX-99.1 23422
6 GRAPHIC g869952dsp1.jpg GRAPHIC 9177
  Complete submission text file 0001193125-24-186674.txt   187075

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gh-20240729.xsd EX-101.SCH 2854
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gh-20240729_lab.xml EX-101.LAB 17236
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gh-20240729_pre.xml EX-101.PRE 10817
17 EXTRACTED XBRL INSTANCE DOCUMENT d869952d8k_htm.xml XML 3496
Mailing Address 3100 HANOVER STREET PALO ALTO CA 94304
Business Address 3100 HANOVER STREET PALO ALTO CA 94304 855-698-8887
Guardant Health, Inc. (Filer) CIK: 0001576280 (see all company filings)

IRS No.: 454139254 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38683 | Film No.: 241148790
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)